Doximity, Inc. (NASDAQ:DOCS) Director Sells $315,000.00 in Stock

Doximity, Inc. (NASDAQ:DOCS) Director Regina M. Benjamin sold 5,000 shares of the business’s stock in a transaction on Friday, August 8th. The stock was sold at an average price of $63.00, for a total transaction of $315,000.00. Following the transaction, the director owned 16,618 shares of the company’s stock, valued at approximately $1,046,934. The trade was a 23.13% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink.

Doximity Trading Up 3.5%

Shares of DOCS stock opened at $63.99 on Thursday. The company has a market capitalization of $12.02 billion, a P/E ratio of 63.99, a price-to-earnings-growth ratio of 4.10 and a beta of 1.36. The business’s 50 day moving average is $59.77 and its two-hundred day moving average is $60.14. Doximity, Inc. has a twelve month low of $34.34 and a twelve month high of $85.21.

Doximity (NASDAQ:DOCS) last announced its quarterly earnings data on Thursday, August 7th. The company reported $0.36 earnings per share for the quarter, beating analysts’ consensus estimates of $0.31 by $0.05. Doximity had a return on equity of 21.75% and a net margin of 36.60%. During the same period last year, the firm posted $0.28 EPS. Doximity’s quarterly revenue was up 15.2% compared to the same quarter last year. As a group, equities analysts predict that Doximity, Inc. will post 0.99 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

DOCS has been the topic of several research analyst reports. Raymond James Financial raised their target price on Doximity from $65.00 to $75.00 and gave the stock an “outperform” rating in a research report on Friday, August 8th. Needham & Company LLC boosted their price target on shares of Doximity from $67.00 to $75.00 and gave the company a “buy” rating in a research report on Friday, August 8th. Mizuho decreased their price objective on shares of Doximity from $65.00 to $60.00 and set a “neutral” rating for the company in a research note on Friday, May 16th. Robert W. Baird dropped their price objective on Doximity from $87.00 to $65.00 and set an “outperform” rating on the stock in a report on Tuesday, May 20th. Finally, BTIG Research upgraded Doximity from a “neutral” rating to a “buy” rating and set a $80.00 target price on the stock in a research report on Monday, June 2nd. Ten investment analysts have rated the stock with a hold rating, ten have assigned a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $66.21.

Institutional Trading of Doximity

A number of institutional investors have recently modified their holdings of the business. Baird Financial Group Inc. purchased a new position in Doximity in the second quarter worth $4,139,000. Twin Peaks Wealth Advisors LLC purchased a new stake in shares of Doximity during the 2nd quarter worth $629,000. Edgestream Partners L.P. grew its stake in shares of Doximity by 92.7% during the 2nd quarter. Edgestream Partners L.P. now owns 80,114 shares of the company’s stock worth $4,914,000 after purchasing an additional 38,540 shares during the period. Norges Bank purchased a new position in shares of Doximity in the 2nd quarter valued at about $6,205,000. Finally, Capital Fund Management S.A. purchased a new position in shares of Doximity in the 2nd quarter valued at about $2,652,000. 87.19% of the stock is currently owned by hedge funds and other institutional investors.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.